Patricia Van Arnum

Patricia Van Arnum was executive editor of Pharmaceutical Technology


Pfizer, Teva Settle Patent Litigation on Viagra

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.

Biogen Idec, Samsung Bioepis Target Anti-TNF Biosimilars in Europe

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.

AstraZeneca Issues Statement on Competitor to Nexium

AstraZeneca issues a statement regarding the launch of esomeprazole strontium in the United States.

GlaxoSmithKline To Invest in UK-Based Manufacturing

GlaxoSmithKline plans to expand its facilities in Ware and Worthing in the United Kingdom and will build a new facility for manufacturing innovation.